Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?

Published:2014-08-22 Issue:10 Volume:27 Page:994-1004
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Li Pengmei¹²,Shuker Nauras¹³,Hesselink Dennis A.³,van Schaik Ron H. N.⁴,Zhang Xianglin²,van Gelder Teun¹³

Affiliation:

1. Department of Hospital Pharmacy; Erasmus Medical Center Rotterdam; Rotterdam The Netherlands

2. Department of Pharmacy; China-Japan Friendship Hospital; Beijing China

3. Department of Internal Medicine; Erasmus Medical Center Rotterdam; Rotterdam The Netherlands

4. Department of Clinical Chemistry; Erasmus Medical Center Rotterdam; Rotterdam The Netherlands

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12382/fullpdf

Reference97 articles.

1. Bioavailability improvement of mycophenolic acid through amino ester derivatization;Lee;Pharm Res,1990

2. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation;Jonge;Ther Drug Monit,2009

3. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?;Cox;Ther Drug Monit,2003

4. Do sex and ethnicity influence drug pharmacokinetics in solid organ transplantation?;Mathis;Graft,2002

5. African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors;Malat;Drugs,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycophenolate Dose Reduction in Tacrolimus-based Regimens and Long-term Kidney Transplant Outcomes in Australia and New Zealand;Transplantation Direct;2024-06-13

2. Therapeutic Drug Monitoring in Patients with Systemic Lupus Erythematosus: Utility and Gaps;Journal of Clinical Medicine;2024-01-13

3. Emerging approaches to induce immune tolerance to therapeutic proteins;Trends in Pharmacological Sciences;2023-12

4. Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment;Best Practice & Research Clinical Rheumatology;2023-12

5. Clinical impact using low-dose mycophenolate mofetil with tacrolimus on infectious, noninfectious complications and acute rejection, in renal transplant: A single hospital experience in Mexico;Medicine;2023-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3